SCHEMBL686588

SCHEMBL686588

N[P]N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL28648406 0.89
SCHEMBL5853801 0.82
Hydrochloric Acid SCHEMBL5604474 0.76
SCHEMBL5853796 0.61
SCHEMBL3837636 0.61
SCHEMBL10911179 0.61
SCHEMBL4465730 0.61
SCHEMBL29354075 0.50
SCHEMBL28942450 0.50
SCHEMBL29797048 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110462042-A Antivirotic MEHARRY MEDICAL COLLEGE 2019-11-15 CN claimed
US-20090312566-A1 Multiply substituted ferrocenes SOLVIAS AG (CH) 2009-12-17 US claimed
EP-1874786-A2 MULTIPLY SUBSTITUTED FERROCENES Solvias AG (CH) 2008-01-09 EP claimed
JP-4014231-B2 2007-11-28 JP claimed
US-20070179321-A1 PROCESS FOR THE PRODUCTION OF 4,4-DIPHENYLCYCLOHEXANOL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-02 US claimed
WO-2007073792-A1 PROCESS FOR PREPARING 4,4- DIPHENYLCYCLOHEXANOL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-07-05 WO claimed
WO-2006114438-A2 MULTIPLY SUBSTITUTED FERROCENES SOLVIAS AG (CH) 2006-11-02 WO claimed
EP-1021452-B1 PROCESS FOR SYNTHESIZING PHOSPHODIESTERS EPIX MEDICAL INC (US) 2003-04-02 EP claimed
JP-2002511060-A 2002-04-09 JP claimed
EP-1021452-A1 PROCESS FOR SYNTHESIZING PHOSPHODIESTERS Epix Medical, Inc. (US) 2000-07-26 EP claimed
US-5919967-A Process for synthesizing phosphodiesters EPIX MEDICAL, INC. (US) 1999-07-06 US claimed
WO-1998046612-A1 PROCESS FOR SYNTHESIZING PHOSPHODIESTERS EPIX MEDICAL, INC. (US) 1998-10-22 WO claimed
CN-110520118-A PRODRUGS OF GLUTAMINE ANALOGS UNIV JOHNS HOPKINS 2019-11-29 CN disclosed
CN-108699555-A Composition for treating Duchenne's dystrophy and associated disease and method 萨勒普塔医疗公司 2018-10-23 CN disclosed
CN-108135872-A For treating the glutamine antagonist of cognitive defect 约翰霍普金斯大学 2018-06-08 CN disclosed
EP-1871782-B1 DIPHOSPHINES AND METAL COMPLEXES UMICORE AG & CO KG (DE) 2012-02-29 EP disclosed
EP-0573633-A1 PROCATALYST COMPOSITION FOR HOMO- AND COPOLYMERIZATION OF ALPHA OLEFINS, ITS PREPARATION AND ITS USE. NESTE OY (FI) 1993-12-15 EP disclosed
WO-1993013141-A1 PROCATALYST COMPOSITION FOR HOMO- AND COPOLYMERIZATION OF ALPHA OLEFINS, ITS PREPARATION AND ITS USE NESTE OY (FI) 1993-07-08 WO disclosed
EP-0511962-A1 PROCATALYST COMPOSITION FOR THE POLYMERIZATION OF -g(a)-OLEFINES, PREPARATION AND USE. NESTE OY (FI) 1992-11-11 EP disclosed
WO-1991008239-A1 PROCATALYST COMPOSITION FOR THE POLYMERIZATION OF α-OLEFINES, PREPARATION AND USE NESTE OY (FI) 1991-06-13 WO disclosed